CC-Chemokine Receptor-2 Expression in Osteoblasts Contributes to Cartilage and Bone Damage during Post-Traumatic Osteoarthritis
暂无分享,去创建一个
H. Ozkan | L. Arbeeva | L. Longobardi | H. Willcockson | F. Prósper | J. Valdés-Fernández | E. Mucahit | Froilán Granero-Moltó | L. Musawwir | Lola B. Hooper | José Valdés-Fernández | Helen Willcockson | Huseyin Ozkan | Liubov Arbeeva | Lola B Hooper
[1] P. Decuzzi,et al. Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis , 2022, Drug Delivery and Translational Research.
[2] F. Cicuttini,et al. Osteophytes mediate the associations between cartilage morphology and changes in knee symptoms in patients with knee osteoarthritis , 2022, Arthritis Research & Therapy.
[3] L. Arbeeva,et al. Early Ablation of Ccr2 in Aggrecan-expressing cells Following Knee Injury Ameliorates Joint Damage and Pain during Post-traumatic Osteoarthritis. , 2022, Osteoarthritis and cartilage.
[4] Wen-qing Xie,et al. Peripheral nerves in the tibial subchondral bone , 2022, Bone & joint research.
[5] Mei Liu,et al. The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseases , 2021, Journal of cellular physiology.
[6] M. Lotz,et al. Histological scoring system for subchondral bone changes in murine models of joint aging and osteoarthritis , 2020, Scientific Reports.
[7] Xinzhong Dong,et al. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain , 2019, The Journal of clinical investigation.
[8] J. Jordan,et al. Associations between the chemokine biomarker CCL2 and knee osteoarthritis outcomes: the Johnston County Osteoarthritis Project. , 2018, Osteoarthritis and cartilage.
[9] D. Holdsworth,et al. Early Changes of Articular Cartilage and Subchondral Bone in The DMM Mouse Model of Osteoarthritis , 2018, Scientific Reports.
[10] T. Myers,et al. Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis. , 2017, Osteoarthritis and cartilage.
[11] A. Malfait,et al. Can we target CCR2 to treat osteoarthritis? The trick is in the timing! , 2017, Osteoarthritis and cartilage.
[12] T. Vincent,et al. CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy , 2017, Osteoarthritis and cartilage.
[13] L. Leng,et al. Reduced Osteoarthritis Severity in Aged Mice With Deletion of Macrophage Migration Inhibitory Factor , 2017, Arthritis & rheumatology.
[14] W. Robinson,et al. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis , 2016, Annals of the rheumatic diseases.
[15] J. Mort,et al. Reduction in Disease Progression by Inhibition of Transforming Growth Factor α–CCL2 Signaling in Experimental Posttraumatic Osteoarthritis , 2015, Arthritis & rheumatology.
[16] A. Carr,et al. Osteoarthritis , 2015, The Lancet.
[17] Baoen Jiang,et al. Serum and synovial fluid chemokine ligand 2/monocyte chemoattractant protein 1 concentrations correlates with symptomatic severity in patients with knee osteoarthritis , 2015, Annals of clinical biochemistry.
[18] Changqing Zhang,et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes , 2013, Arthritis Research & Therapy.
[19] T. Schnitzer,et al. Towards a mechanism-based approach to pain management in osteoarthritis , 2013, Nature Reviews Rheumatology.
[20] Richard J. Miller,et al. CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis , 2012, Proceedings of the National Academy of Sciences.
[21] David B. Burr,et al. Bone remodelling in osteoarthritis , 2012, Nature Reviews Rheumatology.
[22] A. Nagy,et al. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. , 2012, Blood.
[23] C. Cacına,et al. MCP-1 and CCR2 gene variants and the risk for osteoporosis and osteopenia. , 2012, Genetic testing and molecular biomarkers.
[24] G. Herrero-Beaumont,et al. Subchondral bone as a key target for osteoarthritis treatment. , 2012, Biochemical pharmacology.
[25] G. Garlet,et al. Role of CCR2 in orthodontic tooth movement. , 2012, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.
[26] R. Loeser,et al. A Comprehensive Histological Assessment of Osteoarthritis Lesions in Mice , 2011, Cartilage.
[27] Elle L. Parks,et al. Brain activity for chronic knee osteoarthritis: dissociating evoked pain from spontaneous pain. , 2011, European journal of pain.
[28] C. Colnot,et al. Multiple roles for CCR2 during fracture healing , 2010, Disease Models & Mechanisms.
[29] Henning Madry,et al. The basic science of the subchondral bone , 2010, Knee Surgery, Sports Traumatology, Arthroscopy.
[30] Z. Werb,et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. , 2009, Arthritis and rheumatism.
[31] David Felson,et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies , 2009, BMJ : British Medical Journal.
[32] M. Mack,et al. Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis , 2009, Nature Medicine.
[33] S. Burdach,et al. A complex pattern of chemokine receptor expression is seen in osteosarcoma , 2008, BMC Cancer.
[34] A. Tsykin,et al. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signalling , 2007, Arthritis research & therapy.
[35] S. Glasson,et al. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. , 2007, Osteoarthritis and cartilage.
[36] S. Glasson,et al. Osteoarthritis severity is sex dependent in a surgical mouse model. , 2007, Osteoarthritis and cartilage.
[37] D. Walsh,et al. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis , 2007, Annals of the rheumatic diseases.
[38] P. Croft,et al. Symptoms and radiographic osteoarthritis: not as discordant as they are made out to be? , 2006, Annals of the rheumatic diseases.
[39] H. Ma,et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis , 2005, Nature.
[40] B. de Crombrugghe,et al. Transgenic mice expressing a ligand-inducible cre recombinase in osteoblasts and odontoblasts: a new tool to examine physiology and disease of postnatal bone and tooth. , 2004, The American journal of pathology.
[41] H. Ma,et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. , 2004, Arthritis and rheumatism.
[42] W. Kuziel,et al. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. , 2004, The Journal of clinical investigation.
[43] R. E. Guzman,et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. , 2003, Osteoarthritis and cartilage.
[44] J. Mudgett,et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] T. Yaksh,et al. Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.
[46] Johanne Martel-Pelletier,et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.
[47] A. Woolf,et al. Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.